Brief: Brainsway Announces Publication Of Results Demonstrating Efficacy Of Deep TMS In Treating Anxiety Symptoms Comorbid To Depression
23/02/2022 13:21
Feb 23 (Reuters) - Brainsway Ltd BWAY.TA :
* BRAINSWAY ANNOUNCES PUBLICATION OF RESULTS DEMONSTRATING
EFFICACY OF DEEP TMS™ IN TREATING ANXIETY SYMPTOMS COMORBID TO
DEPRESSION
Source text for Eikon: ID:nGNX1B5BjX
Further company coverage: BWAY.TA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Brainsway
See all newsBrief: Brainsway Presents Positive Data From Largest Real-World Study Of Deep Tms™ In Patients With Comorbid Ptsd And Major Depressive Disorder
Brief: Brainsway Announces Minority-Stake Investment In Hopemark Health
Brief: Brainsway Announces New Minority-Stake Investment In Canadian Provider, Brainstim Health Inc.
Brief: Brainsway Announces Change In ADS-To-Ordinary Share Ratio
Brief: BrainsWay Announces FDA Approval of Neurolief’s Proliv™Rx Neuromodulation System for Major Depressive Disorder (MDD)